Preprint · CC-BY
via OpenAlex
Examination of interactions of ellagic acid's secondary metabolites (urolithins) with albumins and extracellular vesicles
CER (University of Belgrade, Institute of Chemistry, Technology and Metallurgy) · 2025
Abstract
Urolitini (URO) su sekundarni metaboliti elaginske kiseline nastale u digestivnom traktu pod dejstvom crevne flore na hranu bogatu elagitaninima. Zbog svoje lipofilne strukture URO prolaze biološke barijere i na taj način dospevaju u cirkulaciju. U cirkulaciji se nalaze u vidu konjugata sa glukuronskom kiselinom ili se vezuju za albumine kako bi se transportovali do tkiva u kojima ispoljavaju antioksidativnu, antiinflamatornu i antikancersku aktivnost.U doktorskoj disertaciji je ispitivano vezivanje urolitina, kao i njihovih glukuronida za serumske albumine kao proteinske nosače metodom fluorescentne spektroskopije. Mehanizam gašenja fluorescencije i konstante vezivanja (Kb) određeni su titracijom rastvora proteina fiksne koncentracije različitim koncentracijama liganda uz merenje intenziteta fluorescencije. Variranjem temperature izračunati su termodinamički parametri interakcija. Promene sekundarnih struktura proteina su praćene primenom infracrvene spektroskopije sa Furijeovom transformacijom i cirkularnim dihroizmom. Rezultati spektroskopskih analiza su upotpunjeni molekulskim dokingom kojim su predviđena mesta vezivanja URO za serumske albumine. Dobijeni rezultati omogućili su bolje razumevanje mehanizma vezivanja i transporta, odnosno farmakodinamiku ovih biološki aktivnih jedinjenja. U ovoj disertaciji su ispitivane i metode inkorporacije URO A, predstavnika klase urolitina, u ekstracelularne vezikule (EV) dobijene iz komercijalnih humanih ćelijskih linija. Ekstracelularne vezikule predstavljaju dobre neproteinske nanonosače zbog svoje veličine, strukture i mogućnosti prolaska različitih bioloških barijera. Značaj inkorporacije URO A u EV je ciljani transport, kao i zaštita ovih jedinjenja od oksidacije i konjugacije u cirkulaciji.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Nevena, Z. (2025). Examination of interactions of ellagic acid's secondary metabolites (urolithins) with albumins and extracellular vesicles. <em>CER (University of Belgrade, Institute of Chemistry, Technology and Metallurgy)</em>. https://openalex.org/W7112054968
Vancouver
Nevena Z. Examination of interactions of ellagic acid's secondary metabolites (urolithins) with albumins and extracellular vesicles. CER (University of Belgrade, Institute of Chemistry, Technology and Metallurgy). 2025.
BibTeX
@unpublished{zelenovi2025Examin,
title = {Examination of interactions of ellagic acid's secondary metabolites (urolithins) with albumins and extracellular vesicles},
author = {Zelenović, Nevena},
journal = {CER (University of Belgrade, Institute of Chemistry, Technology and Metallurgy)},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Breast Cancer Research and Treatment 2014
Open access · CC-BY
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial
Experimental Biology and Medicine 2001
Citation only
Reduced Levels of Thyroid Hormones, Insulin, and Glucose, and Lower Body Core Temperature in the Growth Hormone Receptor/Binding Protein Knockout Mouse
PLoS ONE 2013
Open access · CC-BY
Anti-Remodeling Effects of Rapamycin in Experimental Heart Failure: Dose Response and Interaction with Angiotensin Receptor Blockade
Centre Hospitalier Intercommunal Creteil 2016
Open access · US-GOV
Evaluation de la gêne Oculaire après Injections intravitréennes
journal of ilam university of medical sciences 2018
Open access · CC-BY
Efficacy of Taurine Supplementation on Markers of Atherothrombosis and Atherogenesis Following Exercise Protocol Bruce Modified in Elderly Men with Myocardial Infarction
Frontiers in Endocrinology 2018
Open access · CC-BY